| Forgot Your Password? |
|
|
|
|||||||||||||||
|
Career DevelopmentPrivate Opportunities
Federation of American
Societies for Experimental Biology (FASEB)
|
| Application Deadline: | July 15th |
| Selection by Reviewers: | August |
| Invitations to attend workshops: | September 1st |
| Workshops: | April/May |
| Between Workshops : | Work with Mentors |
| Second Workshop | Following Spring or Fall |
For additional information, contact:
U.S. Bone and Joint Decade
6300 N. River Road
Suite 515
Rosemont, IL 60018
USA
E-Mail: usbjd@usbjd.org
The National Osteoporosis Foundation (NOF) invites applications from qualified investigators for support of clinical or basic research related to the epidemiology, pathogenesis, diagnosis and treatment of osteoporosis. Applicants must have an M.D., Ph.D. or equivalent degree, must have U.S. citizenship or permanent resident status, and must be affiliated with not-for-profit institutions within the U.S., its territories or the Commonwealth of Puerto Rico. Federal agencies and their employees are not eligible. Grant applications may include salaries and up to 14% overhead costs.
Category I: Individuals at the beginning or early in their faculty careers beyond postdoctoral training (1 -10 years of receiving their PhD or MD) with limited experience in metabolic bone disease research.
Category II: Individuals who are early in their careers as osteoporosis researchers and wish to further their research efforts in osteoporosis.
Category III: Individuals interested in extending already established careers in osteoporosis research into areas that require substantial preliminary data or other help to become competitive for more definitive funding.
A full page letter of intent that clearly describes the proposed research project and specific objectives is due by December 1, 2007. Requests for full research proposals will be made by December 21, 2007. Submission deadline for complete proposals is February 20, 2008. The letter of intent should include the following:
The letter of intent can be faxed to 202-223-1726 - Grants Coordinator, Education & Research.
For additional information, contact Betty Hawkins, Resarch and Education Assistant, researchgrants@nof.org or write to Robert Recker, M.D., Chairman, Research Subcommittee, National Osteoporosis Foundation, 1232 22nd Street, NW, Washington, DC 20037. More information is also available at www.nof.org/grants/.
The Osteogenesis Imperfecta Foundation, Inc. invites applications for OI Foundation
Michael Geisman Research Fellowships. Funding is available for fellowships for
young investigators working to develop expertise in OI research.
2008 Funding:
Michael Geisman Research Fellowships will be funded at up to $50,000 per year
($35,000 toward the investigator's salary and up to $15,000 per year for supplies),
one for basic and one for clinical research. Second year funding may be available.
Seed Grants for basic or clinical studies with relevance to OI may be funded at up to
$60,000 for one year. Seed grants do not support indirect costs or principal
investigators’ salaries. (No reference letters required.)
Clinical Seed Grants may be funded at up to $120,000 for two years (grants do not
support indirect costs or principal investigator salaries). In addition to projects at
institutions, these grants offer an opportunity to study people with OI and their families at
the OI Foundation's National Conference, scheduled for summer 2004. Population
demographics are available from the OI Foundation. (No reference letters required.)
The Osteogenesis Imperfecta (OI) Foundation, Inc. was organized in 1970 as a 501(c)(3)
voluntary national health organization dedicated solely to alleviating problems
associated with osteogenesis imperfecta. The purpose of the OI Foundation is to
improve the quality of life for individuals affected with OI, through funding
research into the causes, treatment, and eventual cure of OI, and through education,
awareness, and mutual support.
The deadline for submissions is November 1, 2007. Grant application forms are available on the OI Foundation's website www.oif.org, or by mail or fax. Funding begins July 1 or October 1, 2008. Previously submitted proposals are eligible for competitive resubmission.
Osteogenesis Imperfecta Foundation
804 West Diamond Avenue, Suite 210
Gaithersburg, Maryland, 20878 USA
(301) 947-0083
(301) 947-0456
bonelink@oif.org
www.oif.org
The International Myeloma Foundation (IMF) awards the Brian D. Novis Research Grant in December of each year. This $40,000 grant will go to a researcher/doctor working in the field of multiple myeloma. For information concerning eligibility, deadline, criteria and applications, please contact:
International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, California 91607 USA
Phone: (818) 487-7455
Fax: (818) 487-7454
E-Mail: TheIMF@myeloma.org
The International Myeloma Foundation disseminates information regarding the latest treatment and management for multiple myeloma, and provides many services, including:
Endocrine Fellows Foundation (EFF) was founded in 1990 to provide support to endocrine fellows in such areas as education, research grant funding, and career guidance. Another goal is to provide both fellows and endocrinology professionals with cutting-edge research results on developments in the fields of endocrinology, metabolism, and diabetology. These goals are accomplished through ongoing programs, including research grants to fellows, professional publications, and scientific forums. These resources are also available to other physicians in training with an interest in endocrine and metabolic diseases. Each academic year, the EFF awards a maximum of 24 research grants.
For details, contact:
Endocrine
Fellows Foundation
Attn: Marilyn Fishman
Suite 578
5959 W. Century Blvd.
Los Angeles, CA 90045
Phone: (310) 877-6515
Fax: (310) 216-0677
E-Mail: endofellowsfnd@cs.com
The National Marfan Foundation (NMF) accepts applications on a yearly basis for one- or two-year grants in basic, translational or clinical research. Applications with budgets up to $50,000 per year are acceptable. Grant awards are based on peer review by the NMF Scientific Advisory Board with the approval of the NMF Board of Directors. For guidelines and application forms, please visit www.marfan.org.
National Marfan Foundation
22 Manhasset Avenue
Port Washington, NY 11050
Phone: 1-800-8-MARFAN
or (516) 883-8712 ext. 17
Fax: (516) 883-8040
Website www.marfan.org
E-mail: research@marfan.org.
In recognition of her outstanding contributions to lupus research over the course of her long career, the Lupus Foundation of America, Inc. (LFA) has established the Evelyn V. Hess Award, to be given annually to a clinical or basic researcher whose body of work has advanced understanding of the pathophysiology, etiology, epidemiology, diagnosis, or treatment of lupus.
Award Information:
Candidates for this award must meet the following criteria:
Nomination packets must include:
How To Submit Nominations:
Please send all materials to the attention of Susan Drinan-Bowes, via e-mail, at bowes@lupus.org, or by mail to the LFA National Office, 2000 L Street NW, Suite 710, Washington, DC 20036. For questions or additional information, please call 202-349-1153.
The Multiple Myeloma Research Foundation (MMRF) supports one of the scientific community's most innovative and responsive research grant programs. Since the MMRF was founded in 1998, it has raised nearly $55 million to fund more than 130 research grants in more than 70 research institutions around the world.
All grant applicants are selected based on their scientific novelty and significance as well as their potential to advance myeloma research and drug discovery efforts. The MMRF supports innovative research efforts in the most promising areas of multiple myeloma research through several grantmaking programs.
For more information regarding grant award areas, award amounts, and deadlinesplease visit theMMRF website at: http://www.multiplemyeloma.org/research/. Or contact the Foundation via e-mail: themmrf@themmrf.org; or call (203) 972-1250.
Funding Opportunity for study with relevance to the rare bone disease, melorheostosis. A seed grant of $30,000. is offered by the Melorheostosis Association, which has the world’s largest database of melorheostosis patients and a tissue repository at the NIH. Medical Panel Chair, Dr. Fred Kaplan. Grant applications and further in structions are available on the Melorheostosis website at www.melorheostosis.com.
Kathleen Harper, President
Melorheostosis Association
410 East 50th Street
New York, NY 10022
Fax: 212 308-0794
E-Mail: ResearchGrant@melorheostosis.org
The Howard Hughes Medical Institute (HHMI) has announced a new award aimed at researchers who are early in their careers and are at a critical point in establishing their own independent research programs. The HHMI will select up to 70 scientists who will receive six-year, non-renewable appointments to HHMI and substantial research support necessary to move their research in creative, new directions. For more information and application details, please visit www.hhmi.org.
The mission of the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation is to support young scientists in fields that are important to the pharmaceutical industry. The PhRMA Foundation offers competitive rsearch fellowships and grants to young scientists to help them pursue careers in research and education related to drug discovery.
The PhRMA Foundation offers fellowships in five areas:
For specific information including deadlines and how to apply, please visit www.phrmafoundation.org.
| Home | Search | Site Map | Disclaimer | Contact Us |
Privacy Policy Refund/Return Policy Linking Policy